Cochrane Systematic Review: Intravenous beta2-agonists versus intravenous aminophylline for acute asthma
Cochrane Systematic Review: Intravenous beta2-agonists versus intravenous aminophylline for acute asthma
Visit VisitObjectives: To compare the benefit of IV beta(2)-agonists versus IV aminophylline for acute asthma treated in the emergency department and in patients admitted to hospital with acute severe asthma.
